Early oseltamivir initiation and influenza outcomes in kidney transplant recipients: a multicenter real-world study
Authors:
Open Access
- 13 August 2026
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Pharmaceutical Association (2024ZYY01)
This publication has 18 references indexed in Scilit:
- Clinical Impact of Community-Acquired Respiratory Viruses in Patients With Solid Organ TransplantsTransplantation Proceedings, 2024
- Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017Nephrology Dialysis Transplantation, 2023
- Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipientsIntensive Care Medicine, 2019
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and AdolescentsNew England Journal of Medicine, 2018
- A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant RecipientsClinical Infectious Diseases, 2018
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling studyThe Lancet, 2018
- Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09Clinical Infectious Diseases, 2012
- Safety and pharmacokinetics of oseltamivir at standard and high dosagesInternational Journal of Antimicrobial Agents, 2010
- Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral TherapyClinical Infectious Diseases, 2004
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000